Advertisement

International Journal of Hematology

, Volume 80, Issue 5, pp 458–462 | Cite as

Successful Unrelated Cord Blood Transplantation for Epstein-Barr Virus-Associated Lymphoproliferative Disease with Hemophagocytic Syndrome

  • Taikai Toubo
  • Naohiro Suga
  • Shouichi Ohga
  • Akihiko Nomura
  • Yasuhiro Onoe
  • Hidetoshi Takada
  • Toshiro Hara
Case Report

Abstract

We report a case of successful umbilical cord blood transplantation (CBT) for Epstein-Barr virus (EBV)-associated lymphoproliferative disease (LPD) in a 6-year-old girl. The patient had hemophagocytic syndrome with excessive circulating levels of EBV DNA that was refractory to immunochemotherapy. Multiple hepatosplenic lesions favored the diagnosis of EBV-associated LPD, although the aggressive course precluded the histopathologic diagnosis. Unrelated CB cells mismatched at 1 HLA locus were infused after patient conditioning with 900 mg/m2 etoposide, 2 g/m2 cytarabine, 16 mg/kg busulfan, and 200 mg/kg cyclophosphamide. Complete chimeric status was obtained on day 19 posttransplantation. Drug fever and acute graft-versus-host disease of the skin (grade II) were the major complications. A transient increase of EBV DNA 1 year after CBT indicated a primary EBV infection of the donor cells. The patient is alive with no evidence of disease 27 months after CBT. There has been no previous report of successful CBT for EBV-related LPD/lymphoma. CBT can be a curative treatment for the disease, even if no viral memory has been set in the stem cell source.

Key words

Epstein-Barr virus Lymphoproliferative disease Hemophagocytic syndrome Hepatosplenic lymphoma Cord blood transplantation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001;114:761–769.CrossRefPubMedGoogle Scholar
  2. 2.
    Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Ohga S, Nomura A, Takada H, Hara T. Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol. 2002;44:203–215.CrossRefPubMedGoogle Scholar
  4. 4.
    Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15:587–590.CrossRefPubMedGoogle Scholar
  5. 5.
    Suga N, Takada H, Nomura A, et al. Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. Br J Haematol. 2002;116:346–349.CrossRefPubMedGoogle Scholar
  6. 6.
    Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461–473.CrossRefPubMedGoogle Scholar
  7. 7.
    Barker JN, Martin PL, Coad JE, et al. Low incidence of Epstein- Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant. 2001;7:395–399.CrossRefPubMedGoogle Scholar
  8. 8.
    Ohga S, Kanaya Y, Maki H, et al. Epstein-Barr virus-associated lymphoproliferative disease after a cord blood transplant for Diamond-Blackfan anemia. Bone Marrow Transplant. 2000;25:209–212.CrossRefPubMedGoogle Scholar
  9. 9.
    Haut PR, Kovarik P, Shaw PH, Walterhouse D, Jenson HB, Kletzel M. Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation. Bone Marrow Transplant. 2001;27:761–765.CrossRefPubMedGoogle Scholar
  10. 10.
    Imashuku S. Clinical features and treatment strategies of Epstein- Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259–272.CrossRefPubMedGoogle Scholar
  11. 11.
    Arico M, Allen M, Brusa S, et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Haematol. 2002;119:180–188.CrossRefPubMedGoogle Scholar
  12. 12.
    Ohga S, Kimura N, Takada H, et al. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease. Am J Hematol. 1999; 61:26–33.CrossRefPubMedGoogle Scholar
  13. 13.
    Lechowicz MJ, Lin L, Ambinder RF. Epstein-Barr virus DNA in body fluids. Curr Opin Oncol. 2002;14:533–537.CrossRefPubMedGoogle Scholar
  14. 14.
    Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic 78 T-cell lym- phoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003;102:4261–4269.CrossRefPubMedGoogle Scholar
  15. 15.
    Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic 78 T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. Histopathology. 2000;36:127–135.CrossRefPubMedGoogle Scholar
  16. 16.
    Shibuya A, Tsuchihashi T, Watanabe M, et al. Severe chronic active Epstein-Barr virus infection associated with multiple necrotic lesions in the liver. Hepatol Res. 2003;25:447–454.CrossRefPubMedGoogle Scholar
  17. 17.
    Kawa K, Okamura T, Yasui M, Sato E, Inoue M. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus- associated T/NK-cell lymphoproliferative disease. Crit Rev Oncol Hematol. 2002;44:251–257.CrossRefPubMedGoogle Scholar
  18. 18.
    Taketani T, Kikuchi A, Inatomi J, et al. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2002;29:531–533.CrossRefPubMedGoogle Scholar
  19. 19.
    Okamura T, Kishimoto T, Inoue M, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant. 2003;31:105–111.CrossRefPubMedGoogle Scholar
  20. 20.
    Minegishi M, Ohashi Y, Kumaki S, et al. Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. 2001;27:883–886.CrossRefPubMedGoogle Scholar
  21. 21.
    Yagi T, Fujino H, Hirai M, et al. Esophageal actinomycosis after allogeneic peripheral blood stem cell transplantation for extranodal natural killer/T cell lymphoma, nasal type. Bone Marrow Transplant. 2003;32:451–453.CrossRefPubMedGoogle Scholar
  22. 22.
    Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene- modified virus-specific T lymphocytes. Nat Med. 1996;2:551–555.CrossRefPubMedGoogle Scholar
  23. 23.
    Kuzushima K, Yamamoto M, Kimura H, et al. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA- matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol. 1996;103:192–198.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Imashuku S, Hibi S, Todo S, et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant. 1999;23:569–572.CrossRefPubMedGoogle Scholar
  25. 25.
    Weinthal JA, Goldman SC, Lenarsky C. Successful treatment of relapsed Burkitt’s lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant. 2000;25:1311–1313.CrossRefPubMedGoogle Scholar
  26. 26.
    Wilson AD, Morgan AJ. Primary immune responses by cord blood CD4+ T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro. J Virol. 2002;76:5071–5081.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Moretta A, Comoli P, Montagna D, et al. High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production. Clin Exp Immunol. 1997;107:312–320.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Sun Q, Burton RL, Pollok KE, Emanuel DJ, Lucas KG. CD4+ Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cell Immunol. 1999;195:81–88.CrossRefPubMedGoogle Scholar
  29. 29.
    Marshall NA, Howe JG, Formica R, et al. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000;96:2814–2821.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2004

Authors and Affiliations

  • Taikai Toubo
    • 1
  • Naohiro Suga
    • 1
  • Shouichi Ohga
    • 1
  • Akihiko Nomura
    • 1
  • Yasuhiro Onoe
    • 1
  • Hidetoshi Takada
    • 1
  • Toshiro Hara
    • 1
  1. 1.Department of PediatricsGraduate School of Medical Sciences, Kyushu UniversityFukuokaJapan

Personalised recommendations